Table 1 Patient characteristics
From: A novel miRNA biomarker panel associated with mortality in pediatric patients with ARDS
|  | All patients (n = 235) | Survivors (n = 43) | Non-survivors (n = 20) | p-value |
|---|---|---|---|---|
Age, years (IQR) | 4.1 (1.0–11.5) | 8.9 (1.6–13.6) | 10.4 (2.2–12.7) | 0.92 |
Gender, male (%) | 125 (53.2) | 27 (62.8) | 15 (75.0) | 0.34 |
ARDS cause | Â | Â | Â | 0.40 |
 Pulmonary cause (%) | 139 (59.1) | 27 (62.8) | 14 (70.0) |  |
 Non-pulmonary cause (%) | 94 (40.0) | 16 (37.2) | 5 (25.0) |  |
Race (%) | Â | Â | Â | 0.66 |
 African-American | 17 (7.2) | 4 (9.3) | 1 (5.0) |  |
 Asian/Pacific Islander | 15 (6.4) | 5 (11.6) | 2 (10.0) |  |
 Caucasian | 160 (68.1) | 19 (44.2) | 6 (30.0) |  |
 Latino | 84 (35.7) | 11 (25.6) | 8 (40.0) |  |
 Other | 43 (18.3) | 4 (9.3) | 3 (15.0) |  |
Type of respiratory support (%) | Â | Â | Â | 0.45 |
 Mechanical ventilation |  | 36 (83.7) | 16 (80.0) |  |
 High frequency oscillation |  | 1 (4.7) | 2 (10.0) |  |
 CPAP/BiPAP |  | 5 (11.6) | 1 (5.0) |  |
 High flow nasal cannula |  | 1 (4.7) | 1 (5.0) |  |
PRISM score (IQR) | 12 (7–20) | 12 (5.5–17) | 15 (9–19.25) | 0.11 |
Vasopressor use (%) | Â | 12 (27.9) | 9 (45.0) | 0.18 |